Author:
Liu Yunxia,Xu Yefeng,Lin Nong,Jiang Shenjun,Wang Yiqing,Ye Zhaoming
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry,General Medicine,Biophysics
Reference28 articles.
1. Hu, Y., Wan, Y., et al. (2008). Minutes of The second national conference on neoadjuvant chemotherapy of Osteosarcoma Expert Meeting. Chin J Orthop,
28(10), 870–874.
2. Rosen, G., Marcove, R. C., & Huvos, A. G. (1983). Primary osteogenic sarcoma: Eight-year experience with adjuvant chemotherapy. Journal of Cancer Research and Clinical Oncology,
106(supplement), 55–67.
3. Bernthal, N. M., Federman, N., Eilber, F. R., et al. (2012). Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma. Cancer,
118(23), 5888–5893.
4. Meyers, P. A., Gorlick, R., Heller, G., et al. (1998). Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. Journal of Clinical Oncology,
16(7), 2452–2458.
5. Link, M. P., Goorin, A. M., & Miser, A. W. (1986). The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. New England Journal of Medicine,
314(25), 1600–1606.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献